COVID-19 Vaccination Archives - e-Learning for Healthcare
Menu Access our e-learning programmes on the e-LfH Hub Hub Register / Log in >

Posts Tagged ‘COVID-19 Vaccination’

Updates made to the COVID-19 vaccination elearning programme

Posted on: July 8th, 2021 by Alex Drinkall No Comments

Since the COVID-19 vaccination programme went live, the content of the different sessions which make up this programme has been updated and amended as more information about the vaccines and the vaccine programme has become available. For those who have already completed this elearning programme, these updates are detailed below, starting with the most recent.

 

8 July 2021

Pfizer BioNTech, AstraZeneca and Moderna vaccine sessions all updated to include

  • the latest vaccine effectiveness data
  • reference to JCVI interim advice about a booster vaccination programme
  • myocarditis and pericarditis reports following the Pfizer BioNTech and Moderna vaccines
  • capillary leak syndrome reports following AstraZeneca vaccine
  • revised advice on co-administration and giving COVID-19 vaccine when other vaccines have recently been given
  • advice about mixed vaccine schedules
  • JCVI advice about the recommended interval of 8 to 12 weeks between vaccine doses
  • more information about vaccine induced thrombosis and thrombocytopenia syndrome following AstraZeneca vaccine added and updated contraindications and precautions for this vaccine
  • some minor wording changes to all sessions following recent updates to the Green Book COVID-19 chapter and new web­­links added

 

11 May 2021

AstraZeneca session updated to include

  • updated advice from the JCVI that an alternative to the AstraZeneca vaccine should be offered to healthy adults aged under 40 years, not only to healthy adults under 30 years as previously recommended in April

 

21 April 2021

All sessions updated to include

  • new JCVI advice on COVID-19 vaccination for pregnant women

 

AstraZeneca session more substantially updated to include

  • new advice about very rare blood clotting and unusual bleeding condition following vaccination with AstraZeneca vaccine and the subsequent new contraindications and precautions to this vaccine, including changes to age group recommendations

 

Some minor wording changes to all sessions following recent updates to the Green Book COVID-19 chapter and new web­­links and images added.

 

8 April 2021

New knowledge and assessment sessions for the Moderna COVID-19 vaccine added

 

16 February 2021

Core Knowledge, Pfizer BioNTech and AstraZeneca vaccine sessions all updated to include

  • advice on managing allergic history and allergies after first dose
  • updated information and clarification of advice on vaccination in pregnancy

as stated in revised Green Book COVID-19 chapter

 

29 January 2021

Pfizer BioNTech vaccine session:

 

AstraZeneca vaccine session:

  • Change to state multidose vial should be clearly labelled with the date and time of expiry rather than from when it was first punctured

 

Some minor wording changes in Core Knowledge, Pfizer BioNTech and AstraZeneca sessions in response to user feedback or nationally published guidance.

 

20 January 2021

 

Core Knowledge session:

  • Section on Long COVID added,
  • Section on laboratory and pathology staff and social care staff eligibility for vaccination updated to be in line with Green Book COVID-19 chapter
  • Change to wording around immunosuppression to reflect change to Green Book COVID-19 chapter about this

 

Pfizer BioNTech vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Change to wording of description of appearance of Pfizer BioNTech vaccine prior to dilution following change about this in the Pfizer Reg174 HCP Information document
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

 

AstraZeneca vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Minor wording changes to “how does the vaccine work” in response to user feedback for clarity
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

 

8 January 2021

  • Advice about obtaining an additional dose from COVID-19 Vaccine AstraZeneca vials added to AstraZeneca session
  • More information about recommended interval between first and second dose added to both AstraZeneca and Pfizer BioNTech sessions
  • More information added to section about information to provide to recipients following vaccination in both AstraZeneca and Pfizer BioNTech sessions.

 

31 December 2020

  • New knowledge and assessment sessions on the AstraZeneca COVID-19 vaccine added
  • Core Knowledge and Pfizer BioNTech vaccine sessions updated to include: revised advice from JCVI on pregnancy and breastfeeding, updated statement from JCVI about scheduling of vaccine doses (between 4 and 12 weeks),
  • Pfizer BioNTech session updated to include: advice on obtaining a 6th dose from a vial, and allergy precautions as stated in updated Green Book COVID-19 chapter and updated Information for Healthcare Professionals on Pfizer BioNTech COVID-19 vaccine document

 

December 2020

  • Core Knowledge session updated with advice about not giving COVID-19 vaccine to pregnant or breastfeeding women after the COVID-19 mRNA Vaccine BNT162b2 (Pfizer BioNTech) was authorised for use
  • New MHRA guidance added on not giving COVID-19 mRNA Vaccine BNT162b2 to those with a history of anaphylaxis to a vaccine, medicine or food or a previous dose of the vaccine and addition of 15 minute minimum observation period following vaccination
  • Some amendments to the COVID-19 mRNA Vaccine BNT162b2 session storage and reconstitution sections following republication of updated Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine document

Updates made to the COVID-19 vaccination e-learning programme

Posted on: May 18th, 2021 by Alex Drinkall No Comments

Since the COVID-19 vaccination programme went live, the content of the different sessions which make up this programme has been updated and amended as more information about the vaccines and the vaccine programme has become available. For those who have already completed this e-learning programme, these updates are detailed below, starting with the most recent.

11 May 2021

AstraZeneca session updated to include

  • updated advice from the JCVI that an alternative to the AstraZeneca vaccine should be offered to healthy adults aged under 40 years, not only to healthy adults under 30 years as previously recommended in April 2021.

 

21 April 2021

All sessions updated to include

  • new JCVI advice on COVID-19 vaccination for pregnant women

 

AstraZeneca session more substantially updated to include

  • new advice about very rare blood clotting and unusual bleeding condition following vaccination with AstraZeneca vaccine and the subsequent new contraindications and precautions to this vaccine, including changes to age group recommendations

 

Some minor wording changes to all sessions following recent updates to the Green Book COVID-19 chapter and new web­­links and images added.

 

8 April 2021

New knowledge and assessment sessions for the Moderna COVID-19 vaccine added

 

16 February 2021

Core Knowledge, Pfizer BioNTech and AstraZeneca vaccine sessions all updated to include

  • advice on managing allergic history and allergies after first dose
  • updated information and clarification of advice on vaccination in pregnancy

as stated in revised Green Book COVID-19 chapter

 

29 January 2021

Pfizer BioNTech vaccine session:

 

AstraZeneca vaccine session:

  • Change to state multidose vial should be clearly labelled with the date and time of expiry rather than from when it was first punctured

 

Some minor wording changes in Core Knowledge, Pfizer BioNTech and AstraZeneca sessions in response to user feedback or nationally published guidance.

 

20 January 2021

 

Core Knowledge session:

  • Section on Long COVID added,
  • Section on laboratory and pathology staff and social care staff eligibility for vaccination updated to be in line with Green Book COVID-19 chapter
  • Change to wording around immunosuppression to reflect change to Green Book COVID-19 chapter about this

 

Pfizer BioNTech vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Change to wording of description of appearance of Pfizer BioNTech vaccine prior to dilution following change about this in the Pfizer Reg174 HCP Information document
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

 

AstraZeneca vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Minor wording changes to “how does the vaccine work” in response to user feedback for clarity
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

 

8 January 2021

  • Advice about obtaining an additional dose from COVID-19 Vaccine AstraZeneca vials added to AstraZeneca session
  • More information about recommended interval between first and second dose added to both AstraZeneca and Pfizer BioNTech sessions
  • More information added to section about information to provide to recipients following vaccination in both AstraZeneca and Pfizer BioNTech sessions.

 

31 December 2020

  • New knowledge and assessment sessions on the AstraZeneca COVID-19 vaccine added
  • Core Knowledge and Pfizer BioNTech vaccine sessions updated to include: revised advice from JCVI on pregnancy and breastfeeding, updated statement from JCVI about scheduling of vaccine doses (between 4 and 12 weeks),
  • Pfizer BioNTech session updated to include: advice on obtaining a 6th dose from a vial, and allergy precautions as stated in updated Green Book COVID-19 chapter and updated Information for Healthcare Professionals on Pfizer BioNTech COVID-19 vaccine document

 

December 2020

  • Core Knowledge session updated with advice about not giving COVID-19 vaccine to pregnant or breastfeeding women after the COVID-19 mRNA Vaccine BNT162b2 (Pfizer BioNTech) was authorised for use
  • New MHRA guidance added on not giving COVID-19 mRNA Vaccine BNT162b2 to those with a history of anaphylaxis to a vaccine, medicine or food or a previous dose of the vaccine and addition of 15 minute minimum observation period following vaccination
  • Some amendments to the COVID-19 mRNA Vaccine BNT162b2 session storage and reconstitution sections following republication of updated Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine document

 

Updates made to the COVID-19 vaccination e-learning programme

Posted on: May 5th, 2021 by Alex Drinkall No Comments

Since the COVID-19 vaccination programme went live, the content of the different sessions which make up this programme has been updated and amended as more information about the vaccines and the vaccine programme has become available. For those who have already completed this e-learning programme, these updates are detailed below, starting with the most recent.

 

21 April 2021

All sessions updated to include

  • new JCVI advice on COVID-19 vaccination for pregnant women

 

AstraZeneca session more substantially updated to include

  • new advice about very rare blood clotting and unusual bleeding condition following vaccination with AstraZeneca vaccine and the subsequent new contraindications and precautions to this vaccine, including changes to age group recommendations

 

Some minor wording changes to all sessions following recent updates to the Green Book COVID-19 chapter and new web­­links and images added.

 

8 April 2021

New knowledge and assessment sessions for the Moderna COVID-19 vaccine added

 

16 February 2021

Core Knowledge, Pfizer BioNTech and AstraZeneca vaccine sessions all updated to include

  • advice on managing allergic history and allergies after first dose
  • updated information and clarification of advice on vaccination in pregnancy

as stated in revised Green Book COVID-19 chapter

 

29 January 2021

Pfizer BioNTech vaccine session:

 

AstraZeneca vaccine session:

  • Change to state multidose vial should be clearly labelled with the date and time of expiry rather than from when it was first punctured

 

Some minor wording changes in Core Knowledge, Pfizer BioNTech and AstraZeneca sessions in response to user feedback or nationally published guidance.

 

20 January 2021

 

Core Knowledge session:

  • Section on Long COVID added,
  • Section on laboratory and pathology staff and social care staff eligibility for vaccination updated to be in line with Green Book COVID-19 chapter
  • Change to wording around immunosuppression to reflect change to Green Book COVID-19 chapter about this

 

Pfizer BioNTech vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Change to wording of description of appearance of Pfizer BioNTech vaccine prior to dilution following change about this in the Pfizer Reg174 HCP Information document
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

 

AstraZeneca vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Minor wording changes to “how does the vaccine work” in response to user feedback for clarity
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

 

8 January 2021

  • Advice about obtaining an additional dose from COVID-19 Vaccine AstraZeneca vials added to AstraZeneca session
  • More information about recommended interval between first and second dose added to both AstraZeneca and Pfizer BioNTech sessions
  • More information added to section about information to provide to recipients following vaccination in both AstraZeneca and Pfizer BioNTech sessions.

 

31 December 2020

  • New knowledge and assessment sessions on the AstraZeneca COVID-19 vaccine added
  • Core Knowledge and Pfizer BioNTech vaccine sessions updated to include: revised advice from JCVI on pregnancy and breastfeeding, updated statement from JCVI about scheduling of vaccine doses (between 4 and 12 weeks),
  • Pfizer BioNTech session updated to include: advice on obtaining a 6th dose from a vial, and allergy precautions as stated in updated Green Book COVID-19 chapter and updated Information for Healthcare Professionals on Pfizer BioNTech COVID-19 vaccine document

 

December 2020

  • Core Knowledge session updated with advice about not giving COVID-19 vaccine to pregnant or breastfeeding women after the COVID-19 mRNA Vaccine BNT162b2 (Pfizer BioNTech) was authorised for use
  • New MHRA guidance added on not giving COVID-19 mRNA Vaccine BNT162b2 to those with a history of anaphylaxis to a vaccine, medicine or food or a previous dose of the vaccine and addition of 15 minute minimum observation period following vaccination
  • Some amendments to the COVID-19 mRNA Vaccine BNT162b2 session storage and reconstitution sections following republication of updated Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine document

COVID-19 vaccination e-learning updates

Posted on: March 15th, 2021 by Alex Drinkall No Comments

Since the COVID-19 vaccination programme went live, the content of the different sessions which make up this programme has been updated and amended as more information about the vaccines and the vaccine programme has become available. For those who have already completed this e-learning programme, these updates are detailed below, starting with the most recent.

 

16 February 2021

Core Knowledge, Pfizer BioNTech and AstraZeneca vaccine sessions all updated to include:

  • advice on managing allergic history and allergies after first dose
  • updated information and clarification of advice on vaccination in pregnancy

as stated in revised Green Book COVID-19 chapter

 

29 January 2021

Pfizer BioNTech vaccine session:

AstraZeneca vaccine session:

  • Change to state multidose vial should be clearly labelled with the date and time of expiry rather than from when it was first punctured

Some minor wording changes in Core Knowledge, Pfizer BioNTech and AstraZeneca sessions in response to user feedback or nationally published guidance.

 

20 January 2021

Core Knowledge session:

  • Section on Long COVID added,
  • Section on laboratory and pathology staff and social care staff eligibility for vaccination updated to be in line with Green Book COVID-19 chapter
  • Change to wording around immunosuppression to reflect change to Green Book COVID-19 chapter about this

 

Pfizer BioNTech vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Change to wording of description of appearance of Pfizer BioNTech vaccine prior to dilution following change about this in the Pfizer Reg174 HCP Information document
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

 

AstraZeneca vaccine session:

  • Waste disposal section updated in response to expert feedback
  • Minor wording changes to “how does the vaccine work” in response to user feedback for clarity
  • Addition of ordering via Foundry system by PCN designated sites in response to request to add this from Specialist Pharmacy Service (SPS)
  • Addition of link and reference to the Pfizer BioNTech vaccine healthcare professional’s training and information materials (cvdvaccine.co.uk/)

 

8 January 2021

  • Advice about obtaining an additional dose from COVID-19 Vaccine AstraZeneca vials added to AstraZeneca session
  • More information about recommended interval between first and second dose added to both AstraZeneca and Pfizer BioNTech sessions
  • More information added to section about information to provide to recipients following vaccination in both AstraZeneca and Pfizer BioNTech sessions.

 

31 December 2020

  • New knowledge and assessment sessions on the AstraZeneca COVID-19 vaccine added
  • Core Knowledge and Pfizer BioNTech vaccine sessions updated to include: revised advice from JCVI on pregnancy and breastfeeding, updated statement from JCVI about scheduling of vaccine doses (between 4 and 12 weeks),
  • Pfizer BioNTech session updated to include: advice on obtaining a 6th dose from a vial, and allergy precautions as stated in updated Green Book COVID-19 chapter and updated Information for Healthcare Professionals on Pfizer BioNTech COVID-19 vaccine document

 

December 2020

  • Core Knowledge session updated with advice about not giving COVID-19 vaccine to pregnant or breastfeeding women after the COVID-19 mRNA Vaccine BNT162b2 (Pfizer BioNTech) was authorised for use
  • New MHRA guidance added on not giving COVID-19 mRNA Vaccine BNT162b2 to those with a history of anaphylaxis to a vaccine, medicine or food or a previous dose of the vaccine and addition of 15 minute minimum observation period following vaccination
  • Some amendments to the COVID-19 mRNA Vaccine BNT162b2 session storage and reconstitution sections following republication of updated Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine document

HEE e-LfH COVID-19 vaccination programme launches hit 2 million

Posted on: March 4th, 2021 by Leanne Hargreaves No Comments

Health Education England’s e-Learning for Healthcare (HEE e-LfH) COVID-19 Vaccination programme has passed the milestone of 2 million session launches since going live.

The e-LfH COVID-19 vaccination e-learning programme continues to be an essential part of the vaccination recruitment and training process.  Health and care colleagues are using the resource to develop the knowledge needed to confidently promote high uptake of the COVID-19 vaccine and deliver the vaccination programme effectively.

The programme consists of a core knowledge session, the COVID-19 mRNA Vaccine BNT162b2 Pfizer-BioNTech session, the COVID-19 Vaccine AstraZeneca session and accompanying assessment sessions for each.  New e-learning sessions will be added as each new vaccine becomes available.

Since the COVID-19 vaccination programme went live, the content has been updated and amended as more information about the vaccines and the vaccine programme has become available. Further details about the recent updates can be found on the e-LfH news page.

The wealth of COVID-19 resources available on e-LfH, including the vaccination e-learning, remain free to access by people working in the NHS, the healthcare sector, the independent sector and social care. The online learning resources have proved invaluable to new, existing and returning staff, particularly where traditional learning environments have been unavailable.

More details about the vaccination content can be found on the e-LfH COVID-19 vaccination programme page.

COVID-19 Vaccination e-learning programme now live

Posted on: November 27th, 2020 by Alex Drinkall No Comments

Health Education England e-Learning for Healthcare has worked in partnership with Public Health England and NHS England and NHS Improvement to develop the COVID-19 Vaccination e-learning programme.  The e-learning programme is designed to provide the health and care workforce involved in the national COVID-19 vaccination programme with the knowledge they need to confidently promote high uptake of the vaccine and deliver the vaccine programme effectively.

The programme currently consists of one core knowledge session, which covers subjects including vaccine eligibility and legal aspects, and an accompanying multiple-choice assessment session.  All those undertaking this e-learning should complete the core knowledge session as this is designed to provide essential knowledge about COVID-19 and the key principles of vaccination needed to deliver the vaccine.

The e-learning sessions describe the national COVID-19 vaccination programme for England. Most of the information in the sessions will be relevant for those involved in the programme throughout the UK and Crown Dependencies. However, those undertaking the programme in Northern Ireland, Scotland, Wales and the Crown Dependencies should be aware that some details as to how the programme will be delivered may be different. Vaccinators should therefore ensure that they refer to any country-specific information available, so they are familiar with the details of the programme for the country they are practising in.

This e-learning programme provides theoretical training.  Practical training in vaccine administration, and assessment and sign-off competency is also required before administering the COVID-19 vaccine.

Learners should also complete the vaccine specific session(s), when available, which will provide more detailed information about the vaccine(s). The assessment sessions should be completed after each knowledge session.  More vaccine-specific sessions will be added as and when more COVID-19 vaccines become available.

Additional, complementary, e-learning sessions including Basic Life Support, anaphylaxis and statutory and mandatory training are available to support vaccinators’ training and education.

For more information about the COVID-19 Vaccination programme, including details on how to access, visit the e-LfH website.

e-LfH is a Health Education England Programme in partnership with the NHS and Professional Bodies